Pharmaceutical Industry Reports Plant-based Vaccines Market | Page 2

REPORT DESCRIPTION
Plant-based Vaccines Market – Overview
Plant-based vaccines are derived from antigens produced in genetically modified plants that can be
extracted and purified by conventional methods. These vaccines can either be consumed or applied to
mucosal surfaces. Plants that are commonly used in production of vaccines are tobacco, potato, tomato,
corn, and rice. Currently, there are several transgenic plants used in development of four different types of
vaccines namely: viral vaccines, parasite vaccines, and bacterial vaccines.
Plant-based vaccines can be extensively manufactured at a very cheap cost. Currently, no plant-based
vaccine has received approval from the US Food and Drug Administration (FDA), as these vaccines are
classified under the genetically modified crop category. However, there are several plant-based vaccines in
clinical trials, which are expected to receive approval from FDA during the forecast period.
Increasing number of research and development activities by key players in the market and robust pipeline
of plant-based vaccines is expected to be a major factor driving the global plant-based vaccines market
growth during the forecast period.
© Coherent market Insights. All Rights Reserved